Hospital-acquired (or nosocomial) pneumonia (HAP) is an important cause of morbidity and mortality despite improved prevention, antimicrobial therapy, and supportive care [1]. The treatment of non-ventilator-associated HAP (nvHAP) and ventilator-associated pneumonia (VAP) will be reviewed here.

No history of hospitalization AND receipt of IV antibiotics in last 90 days and no prior respiratory isolation of MRSA or Pseudomonas aeruginosa Azithromycin and doxycycline monotherapy for outpatient CAP is no longer recommended due to high levels of Streptococcus pneumoniae resistance at SHC.

2016年7月14日 · Healthcare-associated pneumonia (HCAP) includes any patient who was hospitalized in an acute care hospital for 2 or more days within 90 days of the infection, or resided in a nursing home or long-term care facility, received recent IV antibiotic therapy, chemotherapy, or wound care within 30 days of the current infection, or attended a hospital ...

The major goals of this evidence-based guideline for the management of HAP, VAP, and HCAP emphasize early, appropriate antibiotics in adequate doses, while avoiding excessive antibiotics by de-escalation of initial antibiotic therapy, based on microbiologic cultures and the clinical response of the patient, and shortening the duration of ...

Health-Care Associated Pneumonia (HCAP), Hospital-Acquired Pneumonia (HAP), and Ventilator-Associated Pneumonia (VAP) pathway is to be used in adult (age > 18 years) patients only. An Infectious Diseases consult is recommended when dealing with complicated or immunocompromised pa

HCAP is defined as pneumonia in a non-hospitalized patient with healthcare contact and at least one of the following risk factors: home infusion therapy or wound care within the prior 30 days, residence in a nursing home or other long-term care facility (LTCF), hospitalization in an acute care hospital for two or more days within the prior 90 ...

Hospital-acquired pneumonia (HAP) and health-care-associated pneumonia (HCAP) are leading causes of death, morbidity, and resource utilization in hospitalized patients, and are associated with a broad range of Gram-positive and Gram-negative ...

Guidelines recommend administration of antibiotics with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa for treatment of healthcare-associated pneumonia (HCAP). It is unclear if this therapy improves outcomes for …

Inappropriate initial antimicrobial therapy (IIAT) has been associated with decreased survival in patients with health care-associated pneumonia (HCAP). We performed a study to determine whether empiric HCAP antibiotic regimens targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudom …

2025年2月12日 · Hospital-acquired pneumonia (HAP), or nosocomial pneumonia, is a lower respiratory infection that was not incubating at the time of hospital admission and that presents...